Caris Life Sciences Ratios (2024-2026) | CAI

Ratios Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 61.31%63.83%71.12%67.06%76.70%80.97%84.93%79.16%
EBT Margin (Quarter) -66.15%-66.65%-28.44%-84.84%-39.58%11.22%27.98%-0.30%
EBIT Margin (Quarter) -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%
EBITDA Margin (Quarter) -66.06%-66.77%-28.44%-84.81%-39.34%11.25%28.05%-0.26%
Operating Margin (Quarter) -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%
Net Margin (Quarter) -89.74%-90.92%-47.68%-105.07%-285.12%11.22%27.98%-0.24%
FCF Margin (Quarter) -70.12%-26.80%-28.14%3.25%25.52%13.55%10.42%
Efficiency
Inventory Average (Quarter) 44.96M56.46M69.96M
Assets Average (Quarter) 969.81M1,055.12M1,144.03M
Equity Average (Quarter) -2400.77M-2470.39M-2549.35M-1073.48M465.63M527.84M585.40M
Invested Capital (Quarter) -2359.59M-2441.95M-2125.70M-2599.86M826.32M854.24M955.76M974.56M
Asset Utilization Ratio (Quarter) 0.670.770.79
Leverage & Solvency
Interest Coverage Ratio (Quarter) -4.90-4.41-2.79-4.53-0.942.427.790.41
Debt to Equity (Quarter) -0.150.830.790.660.64
Debt Ratio (Quarter) 1.100.390.380.340.33
Equity Ratio (Quarter) -7.270.470.490.510.51
Times Interest Earned (Quarter) -4.90-4.41-2.79-4.53-0.942.427.790.41
Valuation
Enterprise Value (Quarter) -66.93M-722.69M-757.01M-800.09M-823.46M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%0.00%-0.01%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -9.09%4.86%10.83%
Return on Invested Capital (Quarter) 0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%